ClinAsia daily schedule consists of developing programs to provide correct information about the chemical making of a new drug, its safety, its formulation strategy and its administration procedure to be followed when provided to the first man.
Using past data about the chemical making, we help our customers create an effective regulatory strategy formulation for good laboratory practice, toxicology and metabolism clinical studies required to support first-human studies.
Non-Clinical Development Program
Previously made development programs to avoid early chemical complexities in Clinical Trials.
Preclinical Estimation
Preclinical Estimation
Our experts at ClinAsia provide a complete range of research services to clients to select the most suitable study design and additional screening method for an investigational agent and there by maintaining the Preclinical estimation.
Chemistry, Manufacturing and Controls Consulting
Chemistry, Manufacturing and Controls Consulting
Taking into account our customers manufacturing facilities, ClinAsia provides regulatory guidance to suit specifications, method creation and validation as well as co-coordinating stability studies.
Pharmacology and Toxicology
Pharmacology and Toxicology
ClinAsia has extensive expertise in pharmacology with preclinical efficiency, efficacy, General Toxicology, Special Toxicology, Genetic Toxicology, reproductive and development toxicology, Safety pharmacology to guide clients through the preclinical phase.
Regulatory Submissions
Regulatory Submissions
ClinAsia has extensive experience preparing all major regulatory submissions, including complex multinational submissions for any type of drug applications.
No comments:
Post a Comment